sglt2 inhibitors vs glp-1 agonists 🔴SGLT2 and Receptor in Diabetic Kidney Disease: Evolving Evidence and Clinical Application⤵️ #2025Review #OpenAccess 🔹https://www.e-dmj.org/journal/view.php?doi=10.4093/dmj.2025.0220 #Cardiology #FOAMed #MedEd #medstudent Diabetic Agents, From Metformin to

They are not intended to diagnose, treat, cure, or prevent any disease, and are not approved for human or animal administration

We make no guarantees about specific outcomes

By prioritizing their health through these injections, busy women can safeguard their long-term wellness while managing the demands of their careers

It is a small, water-loving molecule with pretty good skin penetration abilties

I.ZhangL.PatelM.SandstedtS

Liraglutide (3.0 mg, daily subcutaneous injection, n = 22) or semaglutide (1.0 mg, weekly subcutaneous injection, n = 18) was initiated 74.5 (51.0, 108.3) months post-surgery after a weight regain of 14.7 (10.3, 19.6) %